期刊文献+

重组激活基因突变与免疫缺陷病表型多样性 被引量:3

The diverse phenotypes of RAG mutation associated immunodeficiency
原文传递
导出
摘要 重组激活基因( recombination activating gene, RAG)突变导致一系列严重的免疫缺陷病,包括重症联合免疫缺陷( severe combined immunodeficiency, SCID)、Omenn综合征以及多种其他特殊表型。不同患者因RAG分子表达受影响程度的差异而表现出复杂多样的免疫表型、组织病理学改变和临床表现。RAG完全缺陷分为典型SCID和母源T细胞输入型SCID。RAG残留缺陷包括典型Omenn综合征、非典型Omenn综合征、肉芽肿性炎症、18T细胞优势扩增型以及母源T细胞植入。患者的淋巴细胞分化发育受到完全或者部分阻断,导致反复感染,并且常伴随自身免疫反应,严重威胁生命。该文对RAG免疫缺陷的各种复杂表型进行归纳,为该疾病的正确诊断、针对性治疗以及发病机制研究提供参考。 RAG mutations cause a spectrum of severe immunodeficiencies ranging from classical severe combined immunodeficiency (SCID) and Omenn syndrome to an increasing number of peculiar phenotypes. Based on the distinct levels of RAG expression in various patients, their immunopbenotypes, histopathological findings and clinical manifestations are diverse. The subtypes of RAG-defect diseases have been described as classical SCID, SCID with maternal T cells, classical Omenn syndrome, atypical Omenn syndrome, granuloma- tous inflammation, predominance/expansion of ~/^-T ceils and maternal T-cell engraftment. The complete failure or partial blockage of lymphocyte development and differentiation can cause repeated infections with autoimmune reactions frequently, and may be lethal. Thorough assessment and interpretation of various phenotypes will guide accurate diagnosis, definitive treatment and the mechanism research.
出处 《国际儿科学杂志》 2016年第12期920-924,共5页 International Journal of Pediatrics
基金 国家自然科学基金(30571694) 辽宁省教育厅科学研究一般项目(L2011180)
关键词 重组激活基因 原发性免疫缺陷病 重症联合免疫缺陷 Omenn综合征 Recombination activating genes Primary immunodeficiency Severe combined immunodefi- ciency Omenn syndrome
  • 相关文献

参考文献6

二级参考文献154

  • 1Henter JI, Home A, Arico M, et al. HLH-2004 : Diagnostic and thera- peutic guidelines for hemophagocytic lymphohisticocytosis. Pediatr Blood Cancer,2007,48(2) :124-131.
  • 2Bryceson YT, Pende D, Maul-Pavicic A, et al. A prospective evalua- tion of degranularion assays in the rapid diagnosis of familial he- mophagocytic syndromes. Blood ,2012,119 (12) :2754-2763.
  • 3Trottestam H,Beutel K,Meeths M,et al. Treatment of the X-Linked lymphoproliferative, GrisceUi and Chediak-higashi syndrome by HLH Directed Therapy. Pediatr Blood Cancer, 2009,52 ( 2 ) : 268- 272.
  • 4Clark RH, Stincheombe JC, Day A, et al. Adaptor protein 3-depen- dent microtubule-mediated movement of lyric granules to the immu- nological synapse. Nat Immunol,2003,4 ( 11 ) : 1111-1 120.
  • 5Filipovich AH. Hemophagocytic lymphohisriocytosis(HLH) and re- lated disorders. Hematology Am Soc Hematol Educ Program, 2009, 127-131.
  • 6Westbroek W. Tuchman M. Tinlov B. et al. A novel missense muta-tion(G43S) in the switch I region of Rab27A causing Griscelli Syn- drome. Mol Genet Metab,2008,94(2) :248-254.
  • 7Masri A, Bakri FG, Al-Hussalni M, et al. Griscelli syndrome type 2 : a rare and lethal disorder. J Child Neuro1,2008,23 ( 8 ) :964-967.
  • 8Mancini AJ, Chan LS, Paller AS. Partial albinism with immunodefi- ciency:Griscelli syndrome:report of a case and review of the litera- ture. J Am Acad Dermatol, 1998,38(2 Pt 2) :295-300.
  • 9Pachlopnik Schmid J, Moshous D, Boddaert N, et al. Hematopoietic stem cell transplantation in Griscelli syndrome type 2 : a single-center report on I0 patients. Blood,2009,114 ( 1 ) :211-218.
  • 10Enders A, Zieger B, Schwarz K, et al. Lethal hemophagocytic lym- phohistiocytosis in Hermansky-Pudlak syndrome type II. Blood, 2006,108 ( 1 ) :81-87.

共引文献18

同被引文献4

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部